The Latest Cardiac and Vascular News
ATLANTA, Feb. 17, 2022 /PRNewswire/ — Fourth Quarter and Recent Business Highlights: Achieved record revenue of $79.4 million in the fourth quarter 2021 versus $67.9 million in the fourth quarter of 2020, an increase of 16.9% on a GAAP basis and 18.8 % on a non-GAAP proforma constant currency basis Received FDA approval to launch enrollment […]
SANTA CLARA, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months and full year ended December 31, 2021. Recent Highlights Recognized revenue […]
Partnership to provide capital and expertise to further strengthen company’s leadership as trusted medical device manufacturer SCOTTSDALE, Ariz. & SAN FRANCISCO–(BUSINESS WIRE)–Confluent Medical Technologies (“Confluent”), a leading materials science, development, and manufacturing partner to medical device manufacturers, today announced the closing of a majority investment from TPG Capital, the private […]
Press release Malmö, Sweden, February 17, 2022 Correction of press release: Acarix AB (publ) publishes Year-End Report 2021 The press release published today at 08.00 CET did not include the quarterly report. The quarterly report is included in the press release below, which otherwise correspond to the previously published press release. For more information contact: Christian […]
The new service will allow for frequent follow-ups, immediate medication or treatment adjustment, and more. New York, NY – February 17, 2022 – As the leading telehealth provider making quality healthcare accessible to all Americans, Antidote Health has announced a new core offering to their suite of services that will […]
MONTREAL and CHARLOTTE, N.C., Feb. 16, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer, effective February 15, 2022. Dr. Bharucha is a cardiac electrophysiologist who brings to Milestone over thirty years of […]
Fourth Quarter 2021 Revenue of $3.7 million, a 75% Increase Over Prior Year MINNEAPOLIS, Feb. 15, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results […]
Brings More Than 30 Years of Pharmaceutical and Biotechnology Leadership Experience Supports Cardurion’s Continued Advancement of Growing Pipeline of Cardiovascular Drug Candidates February 16, 2022 08:00 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage biotechnology company focused on the discovery and development of novel, […]
MASON, Ohio,–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced fourth quarter 2021 and full year 2021 financial results. “We achieved several milestones in 2021 including the approval and launch of Hybrid […]
Revenue of €2.2 million corresponding to the first sales of Aeson® hearts Aeson® implants expected to resume in October 2022 Available financial resources providing financial visibility until July 2022 Company actively exploring financing options beyond H1 2022 CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total […]
